Published in World J Surg Oncol on June 26, 2006
Multimodal management of neuroendocrine liver metastases. HPB (Oxford) (2010) 1.21
Multimodality treatment of unresectable hepatic metastases from pancreatic glucagonoma. Rare Tumors (2009) 0.85
Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis. HPB (Oxford) (2011) 0.82
MRI-guided laser ablation of neuroendocrine tumor hepatic metastases. Acta Radiol Short Rep (2014) 0.79
Radioembolization with yttrium-90 resin microspheres for neuroendocrine tumor liver metastases. Diagn Interv Radiol (2015) 0.79
Treatment of neuroendocrine tumor liver metastases. Int J Hepatol (2012) 0.76
Expression of CD24, a Stem Cell Marker, in Pancreatic and Small Intestinal Neuroendocrine Tumors. Am J Clin Pathol (2015) 0.76
Ki67 score as a potential predictor in the selection of liver-directed therapies for metastatic neuroendocrine tumors: a single institutional experience. J Gastrointest Oncol (2016) 0.75
Comparison study of gastrinomas between gastric and non-gastric origins. World J Surg Oncol (2015) 0.75
Selective internal radiation therapy in patients with progressive neuroendocrine liver metastases. Eur J Nucl Med Mol Imaging (2015) 0.75
Carcinoid tumors. An analysis of 2,837 cases. Cancer (1975) 4.62
The classification of carcinoid tum ours. Lancet (1963) 3.85
Hepatic neuroendocrine metastases: does intervention alter outcomes? J Am Coll Surg (2000) 2.60
Somatostatin receptor scintigraphy: its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas. A prospective study. Ann Intern Med (1996) 2.51
Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann Surg (2004) 1.99
Early and late complications after radiofrequency ablation of malignant liver tumors in 608 patients. Ann Surg (2004) 1.99
Radiofrequency ablation of 100 hepatic metastases with a mean follow-up of more than 1 year. AJR Am J Roentgenol (2000) 1.95
Hepatic transplantation for primary and metastatic cancers of the liver. Surgery (1991) 1.93
Isolated liver metastases from neuroendocrine tumors: does resection prolong survival? J Am Coll Surg (1998) 1.83
Particle embolization of hepatic neuroendocrine metastases for control of pain and hormonal symptoms. J Vasc Interv Radiol (1999) 1.75
Laparoscopic thermal ablation of hepatic neuroendocrine tumor metastases. Surgery (1997) 1.56
Chromogranin A, neuron specific enolase, carcinoembryonic antigen, and hydroxyindole acetic acid evaluation in patients with neuroendocrine tumors. Cancer (1999) 1.54
Review of the anaesthetic management of 21 patients undergoing laparotomy for carcinoid syndrome. Br J Anaesth (1994) 1.46
Percutaneous radiofrequency ablation of hepatic metastases for symptomatic relief of neuroendocrine syndromes. AJR Am J Roentgenol (2003) 1.45
Chromogranin A as serum marker for neuroendocrine neoplasia: comparison with neuron-specific enolase and the alpha-subunit of glycoprotein hormones. J Clin Endocrinol Metab (1997) 1.38
Liver transplantation for metastatic neuroendocrine carcinoma: an analysis of 103 patients. Transplantation (1998) 1.36
Carcinoid tumors: a 37-year experience. Arch Surg (1982) 1.35
Somatostatin receptor-targeted radionuclide therapy of tumors: preclinical and clinical findings. Semin Nucl Med (2002) 1.33
Results of liver transplantation in the treatment of metastatic neuroendocrine tumors. A 31-case French multicentric report. Ann Surg (1997) 1.29
Current treatment for liver metastases from colorectal cancer. World J Gastroenterol (2003) 1.28
Somatostatin analogue scintigraphy in carcinoid tumours. Eur J Nucl Med (1993) 1.24
Value of somatostatin receptor scintigraphy: a prospective study in gastrinoma of its effect on clinical management. Gastroenterology (1997) 1.23
Result of liver resection as treatment for metastases from noncolorectal cancer. J Surg Oncol (2000) 1.18
Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors. Eur J Endocrinol (1999) 1.17
Transarterial chemoembolization of advanced liver metastases of neuroendocrine tumors--a retrospective single-center analysis. Digestion (2003) 1.14
Radiofrequency ablation for unresectable hepatic tumors. Am J Surg (2001) 1.13
Prognostic variables in patients with gastrointestinal carcinoid tumours. Br J Surg (1994) 1.12
Laparoscopic radiofrequency ablation of neuroendocrine liver metastases. World J Surg (2002) 1.07
Gastrinomas: comparison of MR imaging with CT, angiography, and US. Radiology (1989) 1.07
The carcinoid syndrome. N Engl J Med (1986) 1.01
The carcinoid syndrome: palliation by hepatic artery embolization. AJR Am J Roentgenol (1986) 1.00
Discriminating capacity of indole markers in the diagnosis of carcinoid tumors. Clin Chem (2000) 0.99
Comparison of somatostatin receptor imaging, computed tomography and ultrasound in the clinical management of neuroendocrine gastro-entero-pancreatic tumours. Eur J Nucl Med (1998) 0.99
Hepatic artery embolization for control of symptoms, octreotide requirements, and tumor progression in metastatic carcinoid tumors. J Gastrointest Surg (2002) 0.98
Ablative therapies for liver metastases of digestive endocrine tumours. Endocr Relat Cancer (2003) 0.98
Radiofrequency ablation treatment of refractory carcinoid hepatic metastases. J Surg Res (2001) 0.94
Radiofrequency tissue ablation using cooled tip for liver metastases of endocrine tumors. World J Surg (2002) 0.94
Liver transplantation for neuroendocrine tumors. J Gastrointest Surg (2004) 0.93
Hepatic surgery for metastatic gastrointestinal neuroendocrine tumors. Cancer Control (2002) 0.91
Evaluation of whole blood serotonin and plasma and urine 5-hydroxyindole acetic acid in diagnosis of carcinoid disease. Ann Clin Biochem (2002) 0.90
Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors. AJR Am J Roentgenol (1998) 0.90
5-Hydroxytryptamine and 5-hydroxytryptamine-3 receptor antagonists. Scand J Gastroenterol Suppl (1991) 0.90
Serotonin, catecholamines, histamine, and their metabolites in urine, platelets, and tumor tissue of patients with carcinoid tumors. Clin Chem (1994) 0.89
Liver transplantation for treatment of metastatic neuroendocrine tumors. Ann N Y Acad Sci (2004) 0.88
Iodine-131 metaiodobenzylguanidine treatment for metastatic carcinoid. Results in 98 patients. Cancer (2004) 0.88
Clinical effects of octreotide compared to placebo in patients with gastrointestinal neuroendocrine tumours. Report on a double-blind, randomized trial. J Intern Med (1995) 0.87
Highlights of the biology of endocrine tumours of the gut and pancreas. Endocr Relat Cancer (2003) 0.87
Multipolar radiofrequency ablation of large hepatic metastases of endocrine tumours. Eur J Gastroenterol Hepatol (2006) 0.86
The role of interferons in the management of carcinoid tumours. Br J Haematol (1991) 0.84
Octreotide treatment of carcinoid hypertensive crisis. Mt Sinai J Med (1994) 0.84
Staging of digestive endocrine tumours using helical computed tomography and somatostatin receptor scintigraphy. Ann Oncol (2003) 0.82
Usefulness of chromogranin A as a marker for detection of relapses of carcinoid tumours. Clin Chem Lab Med (1998) 0.82
Multiple fiber laser-induced thermotherapy for ablation of large intrahepatic tumors. Photomed Laser Surg (2006) 0.81
Perianaesthetic risks and outcomes of abdominal surgery for metastatic carcinoid tumours. Br J Anaesth (2001) 0.81
Local treatment in unresectable hepatic metastases of carcinoid tumors: Experiences with hepatic artery embolization and radiofrequency ablation. World J Surg Oncol (2005) 0.80
Endocrine tumors of the gastrointestinal tract: systemic treatment. Anticancer Drugs (1994) 0.78
Serotonin release during percutaneous radiofrequency ablation in a patient with symptomatic liver metastases of a neuroendocrine tumor. Hepatogastroenterology (2004) 0.78
[Hepatic chemo-embolization]. Bull Cancer (1989) 0.78
Influence of a serotonin- and dopamine-rich diet on platelet serotonin content and urinary excretion of biogenic amines and their metabolites. Clin Chem (1992) 0.77
Repeated [131I]metaiodobenzylguanidine therapy in two patients with malignant pheochromocytoma. J Clin Endocrinol Metab (2005) 0.76
Adding interferon-alpha to octreotide slows tumour progression compared with octreotide alone but evidence is lacking for improved survival in people with disseminated midgut carcinoid tumours. Cancer Treat Rev (2003) 0.76
Side effects and complications after hepatic artery embolization in the carcinoid syndrome. Scand J Gastroenterol (1991) 0.76
Iodine-131-MIBG therapy of a patient with carcinoid liver metastases. J Nucl Med (1998) 0.76
Meta-analysis of MR imaging in the diagnosis of breast lesions. Radiology (2007) 2.43
Menin links estrogen receptor activation to histone H3K4 trimethylation. Cancer Res (2006) 1.83
Primary hyperparathyroidism in MEN1 patients: a cohort study with longterm follow-up on preferred surgical procedure and the relation with genotype. Ann Surg (2012) 1.78
Factors influencing the local failure rate of radiofrequency ablation of colorectal liver metastases. Ann Surg Oncol (2006) 1.72
Primary colorectal cancers and their subsequent hepatic metastases are genetically different: implications for selection of patients for targeted treatment. Clin Cancer Res (2011) 1.64
Additional value of contrast enhanced intraoperative ultrasound for colorectal liver metastases. Eur J Radiol (2007) 1.60
The finding of invasive cancer after a preoperative diagnosis of ductal carcinoma-in-situ: causes of ductal carcinoma-in-situ underestimates with stereotactic 14-gauge needle biopsy. Ann Surg Oncol (2003) 1.48
Unilateral subtotal adrenalectomy for pheochromocytoma in multiple endocrine neoplasia type 2 patients: a feasible surgical strategy. Ann Surg (2011) 1.44
Gastric conduit staple line after esophagectomy: to oversew or not? J Thorac Cardiovasc Surg (2006) 1.44
Is stereotactic large-core needle biopsy beneficial prior to surgical treatment in BI-RADS 5 lesions? Breast Cancer Res Treat (2004) 1.44
Fibrin-thrombin coated sealant increases strength of esophagogastric anastomoses in a rat model. J Surg Res (2012) 1.43
RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors. Endocr Rev (2006) 1.41
Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model. Hepatology (2005) 1.37
Laparoscopic total gastrectomy versus open total gastrectomy for cancer: a systematic review and meta-analysis. Surg Endosc (2012) 1.34
The effect of a multimodal fast-track programme on outcomes in laparoscopic liver surgery: a multicentre pilot study. HPB (Oxford) (2009) 1.25
Accelerated perinecrotic outgrowth of colorectal liver metastases following radiofrequency ablation is a hypoxia-driven phenomenon. Ann Surg (2009) 1.24
Diagnostic value of routine aqueous contrast swallow examination after oesophagectomy for detecting leakage of the cervical oesophagogastric anastomosis. ANZ J Surg (2008) 1.22
Control of colorectal metastasis formation by K-Ras. Biochim Biophys Acta (2005) 1.22
Liver regeneration is an angiogenesis- associated phenomenon. Ann Surg (2002) 1.21
Surgical implantation of an abdominal imaging window for intravital microscopy. Nat Protoc (2013) 1.19
Oncogenic K-Ras turns death receptors into metastasis-promoting receptors in human and mouse colorectal cancer cells. Gastroenterology (2010) 1.16
Differentiated human colorectal cancer cells protect tumor-initiating cells from irinotecan. Gastroenterology (2011) 1.15
Prognostic significance of successful ablation with radioiodine of differentiated thyroid cancer patients. Eur J Endocrinol (2005) 1.15
Hemorrhoidal artery ligation procedure with or without Doppler transducer in grade II and III hemorrhoidal disease: a blinded randomized clinical trial. Ann Surg (2012) 1.12
Feasibility of robot-assisted laparoscopic surgery: an evaluation of 35 robot-assisted laparoscopic cholecystectomies. Surg Laparosc Endosc Percutan Tech (2002) 1.12
PDGFRB promotes liver metastasis formation of mesenchymal-like colorectal tumor cells. Neoplasia (2013) 1.11
Aortoesophageal fistula successfully treated by endovascular stent-graft. Ann Thorac Surg (2006) 1.10
CD95 is a key mediator of invasion and accelerated outgrowth of mouse colorectal liver metastases following radiofrequency ablation. J Hepatol (2010) 1.10
The multiple endocrine neoplasia type 1 (MEN1) tumor suppressor regulates peroxisome proliferator-activated receptor gamma-dependent adipocyte differentiation. Mol Cell Biol (2009) 1.08
Radiofrequency ablation of colorectal liver metastases induces an inflammatory response in distant hepatic metastases but not in local accelerated outgrowth. J Surg Oncol (2010) 1.08
End-to-end versus end-to-side esophagogastrostomy after esophageal cancer resection: a prospective randomized study. Ann Surg (2014) 1.07
Primary lymphoma of the liver - A complex diagnosis. World J Radiol (2012) 1.07
Residual Esophageal Cancer After Neoadjuvant Chemoradiotherapy Frequently Involves the Mucosa and Submucosa. Ann Surg (2015) 1.07
Robot-assisted endoscopic surgery: a four-year single-center experience. Dig Surg (2005) 1.06
Differential Notch and TGFbeta signaling in primary colorectal tumors and their corresponding metastases. Cell Oncol (2008) 1.06
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors. Mod Pathol (2012) 1.06
Incidence and risk factors of the intraoperative localization failure of nonpalpable breast lesions by radio-guided occult lesion localization: a retrospective analysis of 579 cases: reply. World J Surg (2013) 1.06
Atypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918. J Clin Endocrinol Metab (2002) 1.05
Efficacy and complications of nasojejunal, jejunostomy and parenteral feeding after pancreaticoduodenectomy. J Gastrointest Surg (2012) 1.05
A comparison of balloon injury models of endovascular lesions in rat arteries. BMC Cardiovasc Disord (2002) 1.02
Assessment of viable tumour tissue attached to needle applicators after local ablation of liver tumours. Dig Surg (2009) 0.99
Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance. Fam Cancer (2012) 0.98
CDH1-related hereditary diffuse gastric cancer syndrome: clinical variations and implications for counseling. Int J Cancer (2011) 0.98
Preoperative imaging of colorectal liver metastases after neoadjuvant chemotherapy: a meta-analysis. Ann Surg Oncol (2012) 0.98
Validation of bioluminescence imaging of colorectal liver metastases in the mouse. J Surg Res (2004) 0.98
Perinecrotic hypoxia contributes to ischemia/reperfusion-accelerated outgrowth of colorectal micrometastases. Am J Pathol (2007) 0.98
Mouse models in liver cancer research: a review of current literature. World J Gastroenterol (2008) 0.98
International survey on esophageal cancer: part I surgical techniques. Dis Esophagus (2009) 0.97
Prognostic value of lymph node micrometastases in breast cancer: a multicenter cohort study. Ann Surg Oncol (2010) 0.96
Imaging strategies in the management of oesophageal cancer: what's the role of MRI? Eur Radiol (2013) 0.96
Viable tumor tissue adherent to needle applicators after local ablation: a risk factor for local tumor progression. Ann Surg Oncol (2011) 0.96
End-to-end cervical esophagogastric anastomoses are associated with a higher number of strictures compared with end-to-side anastomoses. J Gastrointest Surg (2013) 0.95
Dual effect of Kras(D12) knockdown on tumorigenesis: increased immune-mediated tumor clearance and abrogation of tumor malignancy. Oncogene (2005) 0.95
Robot-assisted pancreatic surgery: a systematic review of the literature. HPB (Oxford) (2012) 0.94
Behavioral and psychosocial effects of rapid genetic counseling and testing in newly diagnosed breast cancer patients: design of a multicenter randomized clinical trial. BMC Cancer (2011) 0.92
Targeting tumor vasculature and cancer cells in orthotopic breast tumor by fractionated photosensitizer dosing photodynamic therapy. Cancer Res (2002) 0.92
Surgery and angiogenesis. Biochim Biophys Acta (2004) 0.92
KRAS(D13) Promotes apoptosis of human colorectal tumor cells by ReovirusT3D and oxaliplatin but not by tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res (2006) 0.92
Novel molecular pathways in Gorham disease: implications for treatment. Pediatr Blood Cancer (2013) 0.91
Hemodynamic instability during resection of pheochromocytoma in MEN versus non-MEN patients. Eur J Endocrinol (2011) 0.91
Evolution of surgical treatment of primary hyperparathyroidism in patients with multiple endocrine neoplasia type 2A. Endocr Pract (2011) 0.91
How to define a positive circumferential resection margin in T3 adenocarcinoma of the esophagus. Am J Surg Pathol (2011) 0.91
Calcification of arteries supplying the gastric tube: a new risk factor for anastomotic leakage after esophageal surgery. Radiology (2014) 0.91
Factors predicting outcome of total thyroidectomy in young patients with multiple endocrine neoplasia type 2: a nationwide long-term follow-up study. World J Surg (2010) 0.90
A new clinical scoring system to define pneumonia following esophagectomy for cancer. Dig Surg (2014) 0.90
Clinical review 155: Pheochromocytoma in Von Hippel-Lindau disease. J Clin Endocrinol Metab (2003) 0.90
Minimally invasive ablative therapies for invasive breast carcinomas: an overview of current literature. World J Surg (2007) 0.90
Ageing and hepatic steatosis exacerbate ischemia/reperfusion-accelerated outgrowth of colorectal micrometastases. Ann Surg Oncol (2008) 0.90
Synergistic effect of oncogenic RET and loss of p18 on medullary thyroid carcinoma development. Cancer Res (2008) 0.90
Oncogenic KRAS desensitizes colorectal tumor cells to epidermal growth factor receptor inhibition and activation. Neoplasia (2010) 0.89
Centralization of esophagectomy: how far should we go? Ann Surg Oncol (2014) 0.89
Radiofrequency ablation for unresectable locally advanced pancreatic cancer: a systematic review. HPB (Oxford) (2013) 0.89
Accuracy of Detecting Residual Disease After Cross Neoadjuvant Chemoradiotherapy for Esophageal Cancer (preSANO Trial): Rationale and Protocol. JMIR Res Protoc (2015) 0.89
Do patients with multiple endocrine neoplasia syndrome type 1 benefit from periodical screening? Eur J Endocrinol (2003) 0.88
Subcutaneous nodules pointing towards pancreatic disease: pancreatic panniculitis. Dig Surg (2004) 0.88
Inhibition of amyloid fibril formation of human amylin by N-alkylated amino acid and alpha-hydroxy acid residue containing peptides. Chemistry (2002) 0.88
Sensitization to apoptosis underlies KrasD12-dependent oncolysis of murine C26 colorectal carcinoma cells by reovirus T3D. J Virol (2005) 0.88
Robot-assisted laparoscopic resection of a large paraganglioma: a case report. Surg Laparosc Endosc Percutan Tech (2006) 0.87
Cryoablation induces greater inflammatory and coagulative responses than radiofrequency ablation or laser induced thermotherapy in a rat liver model. Surgery (2009) 0.87
MRI-guided ablation of breast cancer: where do we stand today? J Magn Reson Imaging (2011) 0.87
Multipolar radiofrequency ablation of large hepatic metastases of endocrine tumours. Eur J Gastroenterol Hepatol (2006) 0.86
Does Radiofrequency Ablation Add to Chemotherapy for Unresectable Liver Metastases? Curr Colorectal Cancer Rep (2012) 0.86
Incremental value of arterial and equilibrium phase compared to hepatic venous phase CT in the preoperative staging of colorectal liver metastases: an evaluation with different reference standards. Eur J Radiol (2009) 0.86
Treatment of locally advanced esophageal cancer with surgery and chemoradiation. Curr Opin Gastroenterol (2008) 0.86
Endoscopic corticosteroid injections do not reduce dysphagia after endoscopic dilation therapy in patients with benign esophagogastric anastomotic strictures. Clin Gastroenterol Hepatol (2013) 0.86
Validation of tissue microarray technology in squamous cell carcinoma of the esophagus. Virchows Arch (2008) 0.86
Cyclooxygenase-2 is a target of KRASD12, which facilitates the outgrowth of murine C26 colorectal liver metastases. Clin Cancer Res (2005) 0.86
Dissected sentinel lymph nodes of breast cancer patients: characterization with high-spatial-resolution 7-T MR imaging. Radiology (2011) 0.86